118 related articles for article (PubMed ID: 84471)
1. Excretion of 5-s-cysteinyldopa in humans with genetically dark skin.
Agrup G; Hansson C; Juldorf F; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(1):69-70. PubMed ID: 84471
[TBL] [Abstract][Full Text] [Related]
2. Melanocyte metabolites in the urine of people of different skin colour.
Wirestrand LE; Hansson C; Rosengren E; Rorsman H
Acta Derm Venereol; 1985; 65(4):345-8. PubMed ID: 2413694
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
Morishima T; Hanawa S
Acta Derm Venereol; 1981; 61(2):149-50. PubMed ID: 6165192
[TBL] [Abstract][Full Text] [Related]
4. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of 5-S-cysteinyldopa is enhanced by PUVA and is independent of skin type.
Tardy J; Barrois JP; Bendelac A; Leonard F; Triller R; Jardillier JC; Kalis B
Photodermatol; 1987 Aug; 4(4):205-8. PubMed ID: 3124084
[TBL] [Abstract][Full Text] [Related]
6. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
Graef V; Paul E
Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
[TBL] [Abstract][Full Text] [Related]
7. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
Ito S; Kato T; Fujita K
Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
[TBL] [Abstract][Full Text] [Related]
8. 5-S-cysteinyldopa excretion after treatment with 8-methoxypsoralen and UVA light.
Agrup G; Hansson C; Rorsman H; Rosengren A-M ; Rosengren E; Tegner E
J Invest Dermatol; 1978 Jan; 70(1):25-6. PubMed ID: 618976
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
[TBL] [Abstract][Full Text] [Related]
10. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of melanocytic metabolites in fertile women.
Carstam R; Hansson C; Rorsman H; Rosengren E; Sjöberg NO; Wirestrand LE
Acta Derm Venereol; 1985; 65(6):543-5. PubMed ID: 2420122
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of 5-S-cysteinyldopa in relation to skin type, UVB-induced erythema, and melanocyte proliferation in human skin.
Stierner U; Rosdahl I; Augustsson A; Kågedal B
J Invest Dermatol; 1988 Nov; 91(5):506-10. PubMed ID: 3139773
[TBL] [Abstract][Full Text] [Related]
13. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
Beyer C; Fiedler H; Wohlrab W; Wozniak KD
Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
[No Abstract] [Full Text] [Related]
15. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
Paul E; Graef V; Ruppel R
Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
[TBL] [Abstract][Full Text] [Related]
16. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
Paul E; Graef V; Ruppel R; Hellwich M
Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantitation of 5-S-cysteinyldopa in melanotic and amelanotic melanoma in comparison with nonpigment cell tumors and it's urinary excretion.
Mojamdar M; Ichihashi M; Mishima Y
J Dermatol; 1979 Dec; 6(6):379-82. PubMed ID: 120380
[No Abstract] [Full Text] [Related]
18. Determination of urinary 5-S-cysteinyldopa by high-performance liquid chromatography.
Kågedal B; Pettersson A
J Chromatogr; 1983 Feb; 272(2):287-97. PubMed ID: 6403561
[TBL] [Abstract][Full Text] [Related]
19. UVB-induced melanocyte proliferation and 5-S-cysteinyldopa excretion in dysplastic nevus syndrome.
Stierner U; Augustsson A; Rosdahl I; Kågedal B; Suurküla M
Photodermatol; 1988 Oct; 5(5):218-23. PubMed ID: 3146749
[TBL] [Abstract][Full Text] [Related]
20. [Excretion of 5-S-cysteinyldopa in the urine of Japanese patients with malignant melanoma--a helpful biochemical marker for assessing the progression of disease].
Hanawa S
Nihon Hifuka Gakkai Zasshi; 1983 Mar; 93(4):433-42. PubMed ID: 6411952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
